Stakeholder Call: COVID-19 Vaccine Booster Doses – 10/22/21

Acting FDA Commissioner, Janet Woodcock, M.D. and Director, FDA Center for Biologics Evaluation and Research, Peter Marks, M.D., Ph.D., discuss authorization of booster doses for eligible populations of Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine recipients and Janssen COVID-19 Vaccine recipients 18 and older, as well as the FDA’s authorization of the use of heterologous (“mix and match”) boosters.

Category: News
About The Author